| Therapy with recombinant growth hormone | |
| | |
MedLine Citation:
|
PMID: 18062578 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Therapy with recombinant growth hormone is currently approved for the indications growth hormone deficiency,Turner syndrome, chronic renal failure, small for gestational age (SGA) and Prader-Willi syndrome. Positive experience from on-going clinical studies (e.g. on obesity, type 2 diabetes, Crohn's disease) support an extended range of applications for recombinant growth hormone. However, growth hormone therapy is very expensive. On the other hand, biosimilars are already available that are significantly lower in price. During the coming years, research must show whether the efficacy and safety of biosimilars (including possible new indications) are equal to that of the established preparations. |
| | |
Authors:
|
Martin Wabitsch |
Publication Detail:
|
Type: English Abstract; Journal Article |
Journal Detail:
|
Title: MMW Fortschritte der Medizin Volume: 149 ISSN: 1438-3276 ISO Abbreviation: MMW Fortschr Med Publication Date: 2007 Jun |
Date Detail:
|
Created Date: 2007-12-07 Completed Date: 2008-02-06 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100893959 Medline TA: MMW Fortschr Med Country: Germany |
Other Details:
|
Languages: ger Pagination: 41-3 Citation Subset: IM |
Affiliation:
|
Sektion Pädiatrische Endokrinologie, Universitätsklinik für Kinder- und Jugendmedizin, Ulm. martin.wabitsch@uniklinik-ulm.de |
Vernacular Title:
|
Wachstumshormon bald auch bei Adipositas und Diabetes? |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cost Control
/
trends Crohn Disease / drug therapy* Diabetes Mellitus, Type 2 / drug therapy* Drug Costs / trends Drugs, Generic / adverse effects, economics, therapeutic use Dwarfism / drug therapy* Forecasting Germany Growth Hormone / adverse effects, economics, therapeutic use* Obesity / drug therapy* |
| Chemical | |
Reg. No./Substance:
|
0/Drugs, Generic; 9002-72-6/Growth Hormone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Systemic therapy of colorectal carcinoma
Next Document: Na+/Mg2+ antiport in non-erythrocyte vertebrate cells.